On Monday, uniQure N.V (NASDAQ: QURE) opened higher 3.63% from the last session, before settling in for the closing price of $5.78. Price fluctuations for QURE have ranged from $3.73 to $11.35 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 302.35%. Company’s average yearly earnings per share was noted 36.74% at the time writing. With a float of $42.67 million, this company’s outstanding shares have now reached $47.83 million.
Considering the fact that the conglomerate employs 480 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is -11.39%, operating margin of -716.18%, and the pretax margin is -821.68%.
uniQure N.V (QURE) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of uniQure N.V is 12.45%, while institutional ownership is 76.01%. The most recent insider transaction that took place on Jun 26 ’24, was worth 6,309. In this transaction Chief Medical Officer of this company sold 1,447 shares at a rate of $4.36, taking the stock ownership to the 115,253 shares. Before that another transaction happened on Jun 17 ’24, when Company’s Chief Operating Officer sold 2,936 for $4.81, making the entire transaction worth $14,122. This insider now owns 115,707 shares in total.
uniQure N.V (QURE) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -1.41 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -1.28) by -0.13. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.76 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 36.74% per share during the next fiscal year.
uniQure N.V (NASDAQ: QURE) Trading Performance Indicators
Check out the current performance indicators for uniQure N.V (QURE). In the past quarter, the stock posted a quick ratio of 6.51. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 10.10.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.96, a number that is poised to hit -0.66 in the next quarter and is forecasted to reach -3.06 in one year’s time.
Technical Analysis of uniQure N.V (QURE)
Compared to the last year’s volume of 1.38 million, its volume of 0.79 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 19.23%. Additionally, its Average True Range was 0.51.
During the past 100 days, uniQure N.V’s (QURE) raw stochastic average was set at 29.38%, which indicates a significant increase from 19.92% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 105.46% in the past 14 days, which was lower than the 138.90% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.95, while its 200-day Moving Average is $5.75. Nevertheless, the first resistance level for the watch stands at $6.21 in the near term. At $6.43, the stock is likely to face the second major resistance level. The third major resistance level sits at $6.61. If the price goes on to break the first support level at $5.81, it is likely to go to the next support level at $5.63. Now, if the price goes above the second support level, the third support stands at $5.41.
uniQure N.V (NASDAQ: QURE) Key Stats
There are currently 48,743K shares outstanding in the company with a market cap of 288.73 million. Presently, the company’s annual sales total 15,840 K according to its annual income of -308,480 K. Last quarter, the company’s sales amounted to 2,290 K and its income totaled -44,380 K.
